metformin glp-1 combination weight loss The role of receptor agonists as agents in patients with and without type 2 diabetes Anti-Obesity Effects of Metformin: A

You should contact your GP if you experience: Absence of periods for three consecutive cycles (amenorrhoea) if you previously had regular menstruation Unusually heavy bleeding (soaking through a pad or tampon every hour for several consecutive hours) or passing large clots Bleeding between periods or after intercourse, which requires investigation regardless of medication use Severe pelvic pain that differs from typical menstrual cramping Symptoms of anaemia including persistent fatigue, breathlessness, palpitations, or pallor Seek urgent medical help via NHS 111 or A&E for very heavy bleeding with dizziness or fainting, or severe abdominal pain that could indicate complications such as pancreatitis

[1] [3] Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with similar clinical effects

Improvements plateau at a new baseline after about 6 months of consistent use

GHK-Cu sits in the Growth Factors research category at Prototides and is provided for laboratory research use only